Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer: less is more?
Publication date
2024-09
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Oncology
Citation
Roodhart, J M L & Koopman, M 2024, 'Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer : less is more?', The Lancet Oncology, vol. 25, no. 9, pp. 1104-1105. https://doi.org/10.1016/S1470-2045(24)00397-8